Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00257
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.119
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.312
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.398
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00793
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.435
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
60f:60m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Triglycerides
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.359
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00701
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Fasted Clinical Chemistry / Glucose
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Fasted Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.351
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0442
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.272
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00991
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.411
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0580
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.281
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.243
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.597
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Sodium
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.616
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Potassium
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0468
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.152
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.173
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0484
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.185
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.241
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0785
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.625
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0451
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.964
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
9f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.674
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.975
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.274
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.351
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0168
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.843
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00505
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0685
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.624
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.975
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0282
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.269
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.784
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.647
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
DEXA / Fat/Body weight
|
HET
|
11f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
0.750
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HET
|
5f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.202
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
DEXA / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.413
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
DEXA / Fat mass
|
HET
|
11f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
0.967
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:811m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:87m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:23m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.379
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Carbon dioxide production
|
HET
|
264f:264m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Carbon dioxide production
|
HET
|
882f:882m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Oxygen consumption
|
HET
|
882f:882m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Oxygen consumption
|
HET
|
264f:264m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglyceride
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.913
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.442
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.960
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Heat production (metabolic rate)
|
HET
|
264f:264m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Heat production (metabolic rate)
|
HET
|
882f:882m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.440
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.472
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Dysmorphology / fat distribution
|
HET
|
7f:7m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Dysmorphology / fat distribution
|
HET
|
12f:12m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
9f:10m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0383
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HET
|
5f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.260
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.208
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.487
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.740
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.760
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:87m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:811m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:23m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
2.77×10-07
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.444
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0160
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
9f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.207
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0262
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.726
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Chloride
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.886
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.148
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.441
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.165
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.561
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.449
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
9f:10m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.132
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0224
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Calorimetry / Total food intake
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.105
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Total food intake
|
HET
|
12f:12m
|
Linear Mixed Model framework, LME, not including Weight
|
0.598
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
f:5m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
45f:50m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Calorimetry / Cumulative food intake
|
HET
|
264f:264m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0578
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Iron
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0158
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.921
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.191
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.239
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.422
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.443
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:10m
|
Linear Mixed Model framework, LME, not including Weight
|
0.642
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:87m
|
|
|
NotProcessed |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:811m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:23m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alpha-amylase
|
HET
|
12f:11m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.557
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
HMGU
|
Simplified IPGTT / Glucose response AUC
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.656
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
ICS
|
Simplified IPGTT / Glucose response AUC
|
HET
|
12f:12m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.742
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0531
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.358
|
Successful |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
f:1m
|
|
|
NotProcessed |
Kdm8tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0232
|
Successful |
Kdm8tm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
9f:10m
|
Linear Mixed Model framework, LME, including Weight
|
0.0707
|
Successful |